IL2 and neoplasm: Dannull et al. showed that selectively eliminating CD25+ regulatory T cells by a recombinant IL-2 diphtheria toxin conjugate before tumor RNA-loaded DC vaccination resulted in enhanced cytotoxic T lymphocyte responses in vivo [118].